HBIO vs A

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HBIO

46.5
AI Score
VS
HBIO Wins

A

42.3
AI Score

Investment Advisor Scores

HBIO

47score
Recommendation
HOLD

A

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HBIO A Winner
Revenue 43.48M 5.51B A
Net Income -6.33M 1.01B A
Net Margin -14.6% 18.3% A
Operating Income -2.15M 1.20B A
ROE -85.4% 13.7% A
ROA -8.3% 7.2% A
Total Assets 76.29M 13.97B A
Cash 6.50M 1.76B A
Debt/Equity 4.94 0.50 A
Current Ratio 1.87 2.05 A
Free Cash Flow -1.45M 815.00M A

Relative Price Performance (Last 90 Days)

HBIO 1M: +7.2% · 3M: +37.2% A 1M: +6.4% · 3M: +27.0%

Current Technical Phase

HBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.7% over 20 days), RSI 62

RSI (14): 61.9 · Price: $8.49

A

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 62

RSI (14): 62.4 · Price: $175.98

Fundamentals Snapshot

Metric HBIO A
Market Cap — —
Forward P/E 13.2 26.3
Trailing P/E — 34.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.6% 0.5%
Operating Margin 0.0% 0.3%
EPS -2.31 5.07
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.